Thromboembolic complications several days after a single-dose administration of aspirin

Thrombosis Research

Volumn 89, Issue 3, 1998, Pages 123-127

  Aguejouf, O ^a   Belougne Malfatti, E ^a   Doutremepuich, F ^a   Belon, P ^a   Doutremepuich, C ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Aspirin plasma concentration; Induced thrombosis; Platelet aggregability

Indexed keywords

ACETYLSALICYLIC ACID; LYSINE ACETYLSALICYLATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENCY; LASER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM;

EID: 0032004341     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00302-2     Document Type: Article

References (15)

1. 1. Fields WS. Aspirin for prevention of stroke: A review. Am J Med 1983;14:61-5.
2. 2. Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JG, et al. Protective effects of aspirin against acute myocardial infarction and death in man with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med 1983;309: 396-403.
3. 3. Mustard JF, Kinlough RL, Packham MA. Aspirin in the treatment of cardiovascular disease: A review. Am J Med 1983;14:43-9.
4. 4. Harker L, Fuster U. Pharmacology of platelet inhibitors. J Am Coll Cardiol 1986;8:21B-32B.
5. 5. Weskler BB, Tack-Goldman K, Subramanian VA, Gay WA. Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis. Circulation 1985;71:332-40.
6. 6. Pedersen AK, Fitzgerald GA. Dose-related kinetics of aspirin: Presystemic acetylation of platelet cyclooxygenase. N Engl J Med 1984; 311:1206-11.
7. 7. Moncada S, Vane JR. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull 1978;34:129-135.
8. 1 excretion in healthy subjects. Thromb Res 1987;45:355-61.
9. 9. Cardinal D, Flower R. The electronic aggregometer: A novel device for assessing platelet behavior in blood. J. Pharmacological Methods 1980;135-8.
10. 10. Burch JW, Stanford N, Majerus PW. Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest 1978;61:314-319.
11. 11. Weskler BB, Tack-Goldman K, Subramanian VA, Gay WA. Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis. Circulation 1985;71:332-40.
12. 12. Cohen LS. Clinical pharmacology of acetylsalicylic acid. Semin Thromb Hemostas 1976;2: 146-75.
13. 13. Czevionke RL, Hoak M, Fry GL. Effect of aspirin on thrombin-induced adherence of platelets to cultured vessel wall. J Clin Invest 1978;62:847-856.
14. 14. McManus LM, Hanahan DJ, Pinckard RN. Human platelet stimulation by acetyl glyceryl ether phosphorylcholine. J Clin Invest 1981; 67:903-906.
15. 15. O'Flaherty JT, Wykle RL, Miller CH, Lewis JC, Waite M, Bass DA, McCall CE, DeChatelet LR. 1-O-alkyl-sn-glyceryl-3-phosphorylcholines: A novel class of neutrophil stimulants. Am J Pathol 1981;103:70-79.